Insider Buying Insights for Thursday 9/25: ABSI and JSPR Stocks

Avatar photo

“`html

On Monday, Director Menelas N. Pangalos of Absci (ABSI) bought 95,785 shares at $2.66 each, totaling $254,788. The stock is currently trading lower, hitting a low of $2.48, which is 6.8% below his purchase price. This marks Pangalos’s first insider purchase reported in the past year.

Also on Monday, Director Thomas G. Wiggans of Jasper Therapeutics purchased 41,000 shares for a total of $99,630, at a price of $2.43 per share. Jasper Therapeutics is currently up about 2.4% on Thursday.

“`

The free Daily Market Overview 250k traders and investors are reading

Read Now